Largest study of BRCA1 and BRCA2 carriers refines cancer risk estimates in Asian popu

[News]

A team of clinician-scientists and scientists from the University of Nottingham (Malaysia campus), National Cancer Centre Singapore (NCCS), Cancer Research Malaysia, Nanyang Technological University, Singapore (NTU Singapore), University of Malaya, University of Cambridge, A*STAR's Genome Institute of Singapore (GIS) and other institutions, have conducted the largest study done to date of BRCA1 and BRCA2 (BReast CAncer Gene 1 and 2) carriers in an Asian population and refined breast and ovarian cancer risk estimates for this population.

More... (https://www.news-medical.net/news/20240426/Largest-study-of-BRCA1-and-BRCA2-carriers-refines-cancer-risk-estimates-in-Asian-population.aspx)